THURSDAY, DECEMBER 13, 2018
7:30
Conference Registration and Networking Breakfast
8:30
Chairperson’s Welcome and Opening Remarks
Matt Spiewakowski
Director, Payer Marketing
EMD Serono
8:40
STATE OF THE INDUSTRY Evolution and Emergence of Accumulators Adjustment
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
9:20
PANEL DISCUSSION Measure the Impact of Copay Accumulator Programs on Patients and Manufacturers
MODERATOR:
Eric Grunnet
President
Leap Forward Consulting Group
PANELISTS:
Robin Kahn
Associate Director, Employer Marketing
AbbVie
Alex Keeton
Director, Policy Research and Analytics
BIO
Melinda Haren, R.N.
Senior Director, Access Strategies
Zitter Health Insights
10:05
Networking and Refreshment Break
sponsored by:
10:35
Digging Deeper into the Data to Identify Trends within Co-Pay Support Programs
Arran Standring
Senior Manager, Market Intelligence
RxCrossroads by McKesson
11:20
POWER PANEL Stakeholder Insights — Manage Patient Access and Adherence Challenges
MODERATOR:
James Romano, MPA, MBA
Director, Government Relations
PSI (Patient Services Incorporated)
PANELISTS:
Sheila Arquette
Executive Director
NASP
Gina Murdoch
President and CEO
Multiple Sclerosis Association of America
Gerard Rivera
Chief Executive Officer
Pacific Pharmacy Group and Rx Experts
Kollet Koulianos, MBA
Senior Director, Payer Relations
National Hemophilia Foundation
12:30
Networking Luncheon
1:30
Promoting Patient Education and Informed Discussion to Encourage Adherence
Madelaine Feldman, MD
President
Coalition of State Rheumatology Organizations
2:15
LIVE POLLING Beyond the Debit Card —
Payment Technologies for Copay Accumulator Programs
Bob Raffo
President and CEO
FirstView
3:00
Networking and Refreshment Break
3:30
Copay Needs to Innovate – Get Ready to Face New Challenges
Luke Greenwalt
General Manager
IQVIA's US Patient Access & Affordability Solutions
4:15
CHOOSE BETWEEN TWO INTERACTIVE BREAKOUT DISCUSSIONS
BREAKOUT A Cross-Departmental Perspectives and Challenges for Pharmaceutical CompaniesThis session offers an in-depth look at the various teams and how they are impacted by accumulators (through the lens of individual attendees). Participants will “dig deep” and examine the viewpoints of legal, compliance, operations, market access and finance to provide a more salient understanding of the issues each group faces. I. Legal and Compliance II. Operations III. Finance IV. Market Access FACILITATORS: Steven Pitts Gerard Rivera |
BREAKOUT B Manufacturer Closed Door Summit — Examine and Map Out the Financial Impacts of Copay Accumulator Plans*Pharmaceutical manufacturers and their patients will be hit financially due to copay accumulator plans, therefore finding the keys to navigate these plans is paramount to achieving financial security. FACILITATOR: Rick Fry *The Manufacturer Closed Door Summit is only open to attendees from pharmaceutical/biotech companies. Qualification screenings may be conducted. Final eligibility approval is at the discretion of CBI. Other restrictions may apply. |
5:15
Close of Conference
Networking, Wine and Cheese Reception immediately following the final session
THURSDAY, DECEMBER 13, 2018
7:30
Conference Registration and Networking Breakfast
8:30
Chairperson’s Welcome and Opening Remarks
Matt Spiewakowski
Director, Payer Marketing
EMD Serono
8:40
STATE OF THE INDUSTRY Evolution and Emergence of Accumulators Adjustment
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
9:20
PANEL DISCUSSION Measure the Impact of Copay Accumulator Programs on Patients and Manufacturers
MODERATOR:
Eric Grunnet
President
Leap Forward Consulting Group
PANELISTS:
Robin Kahn
Associate Director, Employer Marketing
AbbVie
Alex Keeton
Director, Policy Research and Analytics
BIO
Melinda Haren, R.N.
Senior Director, Access Strategies
Zitter Health Insights
10:05
Networking and Refreshment Break
sponsored by:
10:35
Digging Deeper into the Data to Identify Trends within Co-Pay Support Programs
Arran Standring
Senior Manager, Market Intelligence
RxCrossroads by McKesson
11:20
POWER PANEL Stakeholder Insights — Manage Patient Access and Adherence Challenges
MODERATOR:
James Romano, MPA, MBA
Director, Government Relations
PSI (Patient Services Incorporated)
PANELISTS:
Sheila Arquette
Executive Director
NASP
Gina Murdoch
President and CEO
Multiple Sclerosis Association of America
Gerard Rivera
Chief Executive Officer
Pacific Pharmacy Group and Rx Experts
Kollet Koulianos, MBA
Senior Director, Payer Relations
National Hemophilia Foundation
12:30
Networking Luncheon
1:30
Promoting Patient Education and Informed Discussion to Encourage Adherence
Madelaine Feldman, MD
President
Coalition of State Rheumatology Organizations
2:15
LIVE POLLING Beyond the Debit Card —
Payment Technologies for Copay Accumulator Programs
Bob Raffo
President and CEO
FirstView
3:00
Networking and Refreshment Break
3:30
Copay Needs to Innovate – Get Ready to Face New Challenges
Luke Greenwalt
General Manager
IQVIA's US Patient Access & Affordability Solutions
4:15
CHOOSE BETWEEN TWO INTERACTIVE BREAKOUT DISCUSSIONS
BREAKOUT A Cross-Departmental Perspectives and Challenges for Pharmaceutical CompaniesThis session offers an in-depth look at the various teams and how they are impacted by accumulators (through the lens of individual attendees). Participants will “dig deep” and examine the viewpoints of legal, compliance, operations, market access and finance to provide a more salient understanding of the issues each group faces. I. Legal and Compliance II. Operations III. Finance IV. Market Access FACILITATORS: Steven Pitts Gerard Rivera |
BREAKOUT B Manufacturer Closed Door Summit — Examine and Map Out the Financial Impacts of Copay Accumulator Plans*Pharmaceutical manufacturers and their patients will be hit financially due to copay accumulator plans, therefore finding the keys to navigate these plans is paramount to achieving financial security. FACILITATOR: Rick Fry *The Manufacturer Closed Door Summit is only open to attendees from pharmaceutical/biotech companies. Qualification screenings may be conducted. Final eligibility approval is at the discretion of CBI. Other restrictions may apply. |
5:15
Close of Conference
Networking, Wine and Cheese Reception immediately following the final session